[1] Siegel R,Naishadham D,Jemal A. Cancer statistics,2013[J]. CA Cancer J Clin,2013,63:11-30. [2] Michalski JM,Lawton C,El Naqa I,et al. Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer[J]. Int J Radiat Oncol Biol Phys,2010,76:361-368. [3] Szabo Z,Agoston P,Major T,et al. Comparison of CT-and MRI-based clinical target volumes for 3-dimensional conformal external-beam radiotherapy of prostate cancer[J]. Magy Onkol,2012,56:267-273. [4] Tanaka H,Hayashi S,Ohtakara K,et al. Usefulness of CT-MRI fusion in radiotherapy planning for localized prostate cancer[J]. J Radiat Res,2011,52:782-788. [5] Hentschel B,Oehler W,Strauss D,et al. Definition of the CTV prostate in CT and MRI by using CT-MRI image fusion in IMRT planning for prostate cancer[J]. Strahlenther Onkol,2011,187:183-190. [6] Sefrova J,Paluska,Odrazka K,et al. Changes in target volumes definition by using MRI for prostate bed radiotherapy planning—preliminary results[J]. Klin Onkol,2010,23:256-263. [7] Lieberfarb ME,Schultz D,Whittington R,et al. Using PSA,biopsy Gleason score,clinical stage,and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy[J]. Int J Radiat Oncol Biol Phys,2002,53:898-903. [8] Teh BS,Bastasch MD,Wheeler TM,et al. IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease[J]. Int J Radiat Oncol Biol Phys,2003,56:184-191. [9] Boehmer D,Maingon P,Poortmans P,et al. Guidelines for primary radiotherapy of patients with prostate cancer[J]. Radiother Oncol,2006,79:259-269. [10] Kestin L,Goldstein N,Vicini F,et al. Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume[J]? Int J Radiat Oncol Biol Phys,2002,54:686-697. [11] Lawton CA,DeSilvio M,Roach M 3rd,et al. An update of the phase Ⅲ trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13,with emphasis on unexpected hormone/radiation interactions[J]. Int J Radiat Oncol Biol Phys,2007,69:646-655. [12] Pommier P,Chabaud S,Lagrange JL,et al. Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01[J]. J Clin Oncol,2007,25:5366-5373. [13] Lawton CA,Michalski J,El-Naqa I,et al. RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer[J]. Int J Radiat Oncol Biol Phys,2009,74:383-387.
2014, Vol. 23 
